These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21437989)

  • 21. Neuroimaging Insights: Kava's (
    Savage K; Sarris J; Hughes M; Bousman CA; Rossell S; Scholey A; Stough C; Suo C
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kava (Piper methysticum) Extract for the Treatment of Nervous Anxiety, Tension and Restlessness.
    Kuchta K; Hladikova M; Thomsen M; Nahrstedt A; Schmidt M
    Drug Res (Stuttg); 2021 Feb; 71(2):83-93. PubMed ID: 33207379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kava (Piper methysticum).
    J Soc Integr Oncol; 2009; 7(4):170-2. PubMed ID: 19883532
    [No Abstract]   [Full Text] [Related]  

  • 24. The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials.
    Smith K; Leiras C
    Complement Ther Clin Pract; 2018 Nov; 33():107-117. PubMed ID: 30396607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice.
    Garrett KM; Basmadjian G; Khan IA; Schaneberg BT; Seale TW
    Psychopharmacology (Berl); 2003 Oct; 170(1):33-41. PubMed ID: 12845414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of kava (Kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes.
    Zou L; Henderson GL; Harkey MR; Sakai Y; Li A
    Phytomedicine; 2004; 11(4):285-94. PubMed ID: 15185840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
    Weiss J; Sauer A; Frank A; Unger M
    Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herbal remedies for anxiety - a systematic review of controlled clinical trials.
    Ernst E
    Phytomedicine; 2006 Feb; 13(3):205-8. PubMed ID: 16428031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality aspects of traditional and industrial Kava-extracts.
    Loew D; Franz G
    Phytomedicine; 2003; 10(6-7):610-2. PubMed ID: 13678252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kava (Piper methysticum).
    Cassileth B
    Oncology (Williston Park); 2011 Apr; 25(4):384-5. PubMed ID: 21618963
    [No Abstract]   [Full Text] [Related]  

  • 31. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure.
    Feltenstein MW; Lambdin LC; Ganzera M; Ranjith H; Dharmaratne W; Nanayakkara NP; Khan IA; Sufka KJ
    Phytother Res; 2003 Mar; 17(3):210-6. PubMed ID: 12672148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kava: an overview.
    Singh YN
    J Ethnopharmacol; 1992 Aug; 37(1):13-45. PubMed ID: 1453702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
    Anke J; Ramzan I
    J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saccade and cognitive function in chronic kava users.
    Cairney S; Clough AR; Maruff P; Collie A; Currie BJ; Currie J
    Neuropsychopharmacology; 2003 Feb; 28(2):389-96. PubMed ID: 12589393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.
    Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA
    Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative elimination of Flavokavines A and B from Kava Kava (Piper methysticum G. Forst) by isoelectric focused adsorptive bubble separation.
    Backleh M; Ekici P; Leupold G; Parlar H
    Naturwissenschaften; 2003 Aug; 90(8):366-9. PubMed ID: 12955226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
    Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
    J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
    Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
    Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Piper methysticum (kava kava).
    Altern Med Rev; 1998 Dec; 3(6):458-60. PubMed ID: 9855570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of oxazepam and an extract of kava roots (Piper methysticum) on event-related potentials in a word recognition task.
    Münte TF; Heinze HJ; Matzke M; Steitz J
    Neuropsychobiology; 1993; 27(1):46-53. PubMed ID: 8515824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.